Verastem Oncology Announces Fourth Quarter and Full-Year 2018 Financial Results and Corporate Developments
Go back to Verastem Oncology Announces Fourth Quarter and Full-Year 2018 Financial Results and Corporate Developments| VERASTEM SHS (NASDAQ: VSTM) | Delayed: 8.37 +0.38 (4.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.99 | 52 Week High | $2.43 | |||
| Open | $8.04 | 52 Week Low | $1.05 | |||
| Day High | $8.65 | P/E | N/A | |||
| Day Low | $8.00 | EPS | $-1.79 | |||
| Volume | 3,056,454 | |||||

